Yibing Bai

2.3k total citations · 1 hit paper
22 papers, 926 citations indexed

About

Yibing Bai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yibing Bai has authored 22 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yibing Bai's work include Cancer Immunotherapy and Biomarkers (6 papers), Gastrointestinal motility and disorders (3 papers) and Lung Cancer Research Studies (3 papers). Yibing Bai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Gastrointestinal motility and disorders (3 papers) and Lung Cancer Research Studies (3 papers). Yibing Bai collaborates with scholars based in China, Germany and United States. Yibing Bai's co-authors include Chenqi Xu, Xingdong Guo, Wei Yang, Jun Guo, Shutan Jiang, Lixin Guo, Xiangdong Liu, Yuanzheng Ma, Jiani Yang and Bo Wu and has published in prestigious journals such as Nature, Cancer Cell and Cancer Research.

In The Last Decade

Yibing Bai

21 papers receiving 919 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity

2023 118 citations Chengsong Yan, Lin Zheng et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yibing Bai China	12	386	378	301	152	86	22	926
Jason E. Toombs United States	21	554 1.4×	542 1.4×	395 1.3×	255 1.7×	122 1.4×	32	1.2k
Daniëlle Raats Netherlands	15	391 1.0×	325 0.9×	158 0.5×	154 1.0×	114 1.3×	28	818
Songtao Lai China	11	314 0.8×	251 0.7×	105 0.3×	168 1.1×	96 1.1×	21	645
Huimin Tian China	18	313 0.8×	448 1.2×	360 1.2×	143 0.9×	83 1.0×	34	1.0k
Weina Yu China	12	511 1.3×	411 1.1×	449 1.5×	294 1.9×	84 1.0×	20	1.2k
Vildan Yasasever Türkiye	19	435 1.1×	458 1.2×	204 0.7×	195 1.3×	64 0.7×	53	957
Yinying Dong China	17	524 1.4×	334 0.9×	164 0.5×	347 2.3×	85 1.0×	30	1.2k
Jean‐Philippe Guégan France	17	320 0.8×	399 1.1×	263 0.9×	117 0.8×	96 1.1×	40	822
Hao‐Chen Wang Taiwan	15	420 1.1×	342 0.9×	253 0.8×	190 1.3×	92 1.1×	30	934

Countries citing papers authored by Yibing Bai

Since Specialization

Citations

This map shows the geographic impact of Yibing Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibing Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibing Bai more than expected).

Fields of papers citing papers by Yibing Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibing Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibing Bai. The network helps show where Yibing Bai may publish in the future.

Co-authorship network of co-authors of Yibing Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Yibing Bai. A scholar is included among the top collaborators of Yibing Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibing Bai. Yibing Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Xin, Yingtong Feng, Jinfeng Li, et al.. (2025). DNMT3a promotes LUAD cell proliferation and metastasis by activating the HDAC7 signalling pathway. International Journal of Biological Sciences. 21(4). 1585–1602. 1 indexed citations

Bai, Yibing, et al.. (2024). Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review. Translational Lung Cancer Research. 13(2). 398–422. 7 indexed citations

Bai, Yibing, Haitao Tao, Fan Zhang, et al.. (2023). Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study. Cancer Cell International. 23(1). 224–224. 2 indexed citations

Li, Tao, Yibing Bai, Ming Gao, et al.. (2023). Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China. Frontiers in Oncology. 13. 1147903–1147903. 4 indexed citations

Yan, Chengsong, Lin Zheng, Shutan Jiang, et al.. (2023). Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell. 41(7). 1276–1293.e11. 118 indexed citations breakdown →

Qin, Shukui, Masashi Kudo, T Meyer, et al.. (2022). LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. Annals of Oncology. 33. S1402–S1403. 54 indexed citations

Bai, Yibing, Jiani Yang, Ying Cui, et al.. (2021). Research Progress of Sirtuin4 in Cancer. Frontiers in Oncology. 10. 562950–562950. 20 indexed citations

Fan, Xiaona, Dan Wang, Wenjing Zhang, et al.. (2021). Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy. Frontiers in Cell and Developmental Biology. 9. 638312–638312. 42 indexed citations

Cui, Ying, Jiani Yang, Yibing Bai, et al.. (2021). ENC1 Facilitates Colorectal Carcinoma Tumorigenesis and Metastasis via JAK2/STAT5/AKT Axis-Mediated Epithelial Mesenchymal Transition and Stemness. Frontiers in Cell and Developmental Biology. 9. 616887–616887. 23 indexed citations

10.

Fang, Lin, Chao Liu, Jing Chen, et al.. (2020). Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Research and Treatment. 53(1). 131–139. 56 indexed citations

11.

Shen, Lin, Yi‐Long Wu, Ying Yuan, et al.. (2020). 552P Safety and efficacy of long-term exposure (LTE) to tislelizumab in Chinese patients with advanced solid tumours. Annals of Oncology. 31. S478–S479. 1 indexed citations

12.

Cui, Ying, Jiani Yang, Yibing Bai, et al.. (2020). miR-424-5p regulates cell proliferation and migration of esophageal squamous cell carcinoma by targeting SIRT4. Journal of Cancer. 11(21). 6337–6347. 17 indexed citations

13.

Bai, Yibing, et al.. (2020). Expression and biological significance of GABRE in colon cancer: An analysis based on data mining of Oncomine and TCGA databases. 1399–1405. 1 indexed citations

14.

Teng, Xiaodong, et al.. (2019). Abstract P4-02-12: Comparison of RT-qPCR with consensus immunohistochemistry by three pathologists for ER, PR, HER2 and Ki-67 in Chinese breast cancer patients. Cancer Research. 79(4_Supplement). P4–2.

15.

Meng, Xiangbo, Xiwei Liu, Xingdong Guo, et al.. (2018). FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 564(7734). 130–135. 208 indexed citations

16.

Guo, Lixin, et al.. (2015). The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis. Journal of Receptors and Signal Transduction. 35(6). 640–645. 114 indexed citations

17.

Bai, Yibing, Jing Xu, Lin Shen, et al.. (2015). 2111 A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC). European Journal of Cancer. 51. S366–S366. 3 indexed citations

18.

Wei, Wei, et al.. (2015). [Effect of Shen warming Pi strengthening method on the expression of serum T cell subsets in IBS-D rats].. PubMed. 35(4). 457–60. 1 indexed citations

19.

Tang, Yanping, et al.. (2013). Curative effect of warming kidney and fortifying spleen recipe on diarrhea-predominant irritable bowel syndrome. Journal of Traditional Chinese Medicine. 33(5). 615–619. 15 indexed citations

20.

Shi, Xiaoshan, Yunchen Bi, Wei Yang, et al.. (2012). Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids. Nature. 493(7430). 111–115. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact